FDA product code DXR: Ballistocardiograph

DXR is the FDA product code for ballistocardiograph. It is a Class II device, regulated under 21 CFR 870.2320 and reviewed by the Cardiovascular panel. FDA has cleared 5 510(k) submissions under DXR, 1 in the last five years, from 5 different applicants. The average 510(k) review took 251 days (median 246); 246 days on average over the last three years.

Classification

FieldValue
Device nameBallistocardiograph
Device classClass II
Regulation21 CFR 870.2320
Review panelCV — Cardiovascular
Medical specialtyCardiovascular
Premarket route510(k)
Third-party 510(k) review eligibleYes

510(k) clearances per year for DXR

YearClearancesAvg. review days
20251246

Compare with all 510(k) review times · Search every DXR clearance

Top DXR applicants

ApplicantClearancesLatest
Cardiosense, Inc.12025-07-22
Corsens Medical , Ltd.12016-11-21
Heartforce Medical, Inc.12009-07-24
Vital Science Corp.11987-08-11
Frantz Medical Development, Ltd.11987-02-06

Most recent DXR clearances

510(k)ApplicantDeviceDecision dateReview days
K243566Cardiosense, Inc.CardioTag™2025-07-22246
K160656Corsens Medical , Ltd.CorSens2016-11-21258
K081603Heartforce Medical, Inc.DIGITAL BALLISTOCARDIOGRAPH, MODEL DGB 3002009-07-24413
K870442Vital Science Corp.QUANTASCOPE1987-08-11189
K863508Frantz Medical Development, Ltd.FRANTZ MEDICAL ELECTRODE1987-02-06150

Recalls for DXR devices

FDA recall records list no recalls for product code DXR.

Frequently asked questions

What is FDA product code DXR?

DXR is the FDA product code for ballistocardiograph. It is a Class II device, regulated under 21 CFR 870.2320 and reviewed by the Cardiovascular panel.

What device class is DXR?

Class II, regulation 21 CFR 870.2320. Typical premarket route: 510(k).

How long does a 510(k) take for product code DXR?

Across 5 cleared submissions the average was 251 days from receipt to decision (median 246).

Which companies have the most DXR clearances?

Cardiosense, Inc. (1); Corsens Medical , Ltd. (1); Heartforce Medical, Inc. (1); Vital Science Corp. (1); Frantz Medical Development, Ltd. (1).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times